共同药业(300966.SZ)：已累计回购0.17%股份

Core Viewpoint - The company, Gongtong Pharmaceutical, has announced a share buyback program, indicating confidence in its stock value and future prospects [1] Summary by Categories Share Buyback Details - As of August 31, 2025, the company has repurchased a total of 197,500 shares through a dedicated securities account via centralized bidding, which represents 0.17% of the company's current total share capital [1] - The highest transaction price during the buyback was 16.05 yuan per share, while the lowest was 13.15 yuan per share [1] - The total amount spent on the buyback was approximately 3.029925 million yuan, excluding transaction fees [1]